AnaptysBio Inc (ANAB): Kapitalflussrechnung
Kennzahl in 1000 USD | TTM 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 232.388 | 234.603 | 91.280 | 17.157 | 10.287 | 63.175 | 75.000 | 8.000 | 5.000 | 10.000 | 16.684 | 17.571 | 15.838 | 5.483 |
Cashflow aus operativer Geschäftstätigkeit | 4.478 | 19.697 | -135.337 | -120.800 | -73.593 | -45.920 | -14.157 | -69.517 | -48.506 | -19.438 | -9.030 | -9.669 | 14.603 | -5.796 |
▸ Operative Cashflow Marge | 1,93% | 8,4% | -148,27% | -704,09% | -715,4% | -72,69% | -18,88% | -868,96% | -970,12% | -194,38% | -54,12% | -55,03% | 92,2% | -105,71% |
Investitionsausgaben (CapEx) | 69 | 87 | 358 | 807 | 358 | 1.366 | 569 | 805 | 1.063 | 290 | 50 | 238 | 145 | 37 |
Cashflow aus Investitionstätigkeit | 248.168 | 228.032 | 95.398 | 144.754 | -394.845 | 38.835 | 94.475 | 131.431 | -142.451 | -243.058 | -50 | -238 | -140 | -37 |
Cashflow aus Finanzierungstätigkeit | -102.814 | -132.613 | 127.054 | -59.297 | 44.017 | 252.298 | -879 | -4.493 | 223.364 | 292.453 | 8.628 | 39.403 | 4.915 | 1.964 |
Freier Cashflow | 4.409 | 19.610 | -135.695 | -121.607 | -73.951 | -47.286 | -14.726 | -70.322 | -49.569 | -19.728 | -9.080 | -9.907 | 14.458 | -5.833 |
▸ Freie Cashflow Marge | 1,9% | 8,36% | -148,66% | -708,79% | -718,88% | -74,85% | -19,63% | -879,02% | -991,38% | -197,28% | -54,42% | -56,38% | 91,29% | -106,38% |
Ausgeschüttete Dividenden | - | - | - | -11.726 | - | - | - | - | - | - | - | - | - | - |
Neuausgabe und Rückkäufe von Stammaktien | -64.202 | -68.626 | -456 | -50.000 | 11.827 | 2.553 | 496 | 3.007 | 230.270 | 294.052 | -1 | 40.848 | 160 | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.